Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Completed NCT05679414

Prevalence of Thrombophilic Gene Polymorphism (MTHFR C677T) in COVID-19patients

Conditions: COVID 19 Associated Coagulopathy

Sex: All

Ages: 18 Years – N/A

Healthy volunteers: 1

Enrollment: 46

Sponsor: Ain Shams University

Location: Egypt

Summary

Aim of the study is to find the prevalence of thrombophilic gene methylene tetrahydrofolate reductase (MTHFR) gene polymorphism in a sample of COVID-19 patients, aiming at early detection of MTHFR mutant patients and guiding preventive therapy.

Eligibility Criteria

Inclusion Criteria:All adult patients diagnosed as COVID -19 by RT-PCR will be includedExclusion Criteria:Patients younger than 18 years old Patients on Antithrombotic treatment before COVID-19.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05679414). StuddyBuddy aggregates publicly available trial information.